INGREDION INC (INGR) Stock Analyst Ratings
USA - NYSE:INGR - US4571871023 - Common Stock
108.49 USD
+2.04 (+1.92%)
108.49 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 77% to INGR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 144.59. This target is 33.27% above the current price.
INGR was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about INGR.
In the previous month the buy percentage consensus was at a similar level.
INGR was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-11-05 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-11-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-05 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-09 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-07 | UBS | Downgrade | Buy -> Neutral |
| 2025-02-05 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-02-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-05 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-15 | UBS | Maintains | Buy -> Buy |
| 2024-11-06 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-11-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-15 | UBS | Maintains | Buy -> Buy |
| 2024-08-09 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2024-08-07 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-08-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-03-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-02-15 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-02-07 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-11-13 | UBS | Maintains | Buy -> Buy |
| 2023-11-08 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-11-01 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-29 | Oppenheimer | Initiate | Outperform |
| 2023-08-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
INGREDION INC / INGR FAQ
Can you provide the average price target for INGREDION INC stock?
13 analysts have analysed INGR and the average price target is 144.59 USD. This implies a price increase of 33.27% is expected in the next year compared to the current price of 108.49.
What is the consensus rating for INGR stock?
The consensus rating for INGREDION INC (INGR) is 76.9231 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover INGREDION INC (INGR) stock?
The number of analysts covering INGREDION INC (INGR) is 13.